Navigation Links
Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product
Date:9/25/2008

Recognizes Scientific Accomplishment in Complement Inhibition and Impact of Soliris on Patients Living with PNH

CHESHIRE, Conn., Sept. 25 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) has received a Prix Galien USA 2008 Award for Best Biotechnology Product for Soliris(R) (eculizumab). The Award recognizes the scientific innovation represented by the complement-inhibition technology of Soliris, and the impact the drug is having on the lives of patients with paroxysmal nocturnal hemolglobinuria (PNH), a rare, debilitating and life-threatening blood disorder.

Soliris is a first-in-class complement inhibitor that selectively blocks the formation of terminal complement, a component of the normal immune system. Patients with PNH lack naturally occurring proteins that ordinarily prevent terminal complement from causing the red blood cell destruction (hemolysis) that is central to the serious morbidities and mortality associated with PNH.

"We are living in the midst of a biological revolution and the breakthrough agents honored by the Prix Galien USA illustrate the substantial research and development necessary to bring the fruits of that revolution in molecular medicine to the clinic," said Gerald Weissmann, M.D., Prix Galien USA committee chair, New York University professor emeritus and editor-in-chief of The FASEB Journal.

"We deeply appreciate this honor, which recognizes more than 15 years of dedicated complement-based research. The Prix Galien award is especially gratifying for the scientists, physicians, patients and advocates involved in the discovery and development of Soliris," said Leonard Bell, M.D., Chief Executive Officer of Alexion. "We are committed to making sure that every pa
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
2. Kuvan Receives Positive Opinion From CHMP for European Approval
3. Corgenix Receives Third U.S. Patent on AtherOx(R) Technology
4. Sustainable Oils Receives Regulatory Approval for Feeding Camelina Meal in Livestock Diets
5. U.S. Genomics Inc. Receives $4.5 Million Investment from BD
6. AdvanDx Receives FDA 510(k) Clearance for Yeast Traffic Light PNA FISH(TM)
7. PLC Systems Receives Delisting Notice From American Stock Exchange
8. Nephros Receives Non-Compliance Notification from AMEX
9. China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII
10. Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules
11. Intact Medical Corporations Intact(R) Excise XL Receives 510(K) Marketing Clearance from the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Philadelphia’s newest entrepreneurial incubation space is ready for business, ... Innovation Center @3401 , a collaborative effort of Drexel ... to help attract and nurture start-up businesses in the region, ... , The Innovation Center @3401 (ic@3401), which is located ... new home of DreamIt Ventures and Point.io ...
(Date:7/29/2014)... July 29, 2014  Sigma-Aldrich Corporation (NASDAQ: ... use, increased its investment in Green Chemistry and donated ... world last year, the Company announced Monday in its ... Changed the World? The report comes ... for being a responsible corporate citizen, including recognition for ...
(Date:7/29/2014)... Quorum Review IRB, the industry ... accreditation by the International Association of Six ... Sigma Deployment Program. The citation recognizes robust organizational ... Quorum’s Lean Six Sigma program was evaluated by ... The designation is a public statement of excellence ...
(Date:7/29/2014)... Bryan, TX (PRWEB) July 29, 2014 ... of autonomous modular cleanrooms, today announced a new leadership ... in the United States and abroad. , Maik ... named as the company’s President charged with leading the ... , “As we enter this stage of development and ...
Breaking Biology Technology:Innovation Center @3401 Opens for Business; DreamIt Ventures and Point.io First Residents 2Innovation Center @3401 Opens for Business; DreamIt Ventures and Point.io First Residents 3Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 2Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 3Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 2Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 3G-CON Manufacturing, Inc. Announces Maik Jornitz as President 2
... , , COLUMBIA, Md., Dec. 16 Martek ... for the fourth quarter and fiscal year ended October 31, 2009. ... $90.4 million in the fourth quarter of fiscal 2008. Net income ... quarter of fiscal 2009, a 5% increase compared with $10.5 million, ...
... , , LAS VEGAS, Dec. 16 Cord Blood America, Inc. ... company ( http://www.cordblood-america.com ) focused on bringing the life saving ... and internationally, said today that it has reduced its debt by ... of 2009 and total debt eliminated for the year now tops ...
... , , ... Inc. (Nasdaq: SQNM ), today announced the appointment of Dr. ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO ) , Kenneth F. Buechler, ... From 1988 to 1994, Dr. Buechler was Biosite,s director of chemistry. ...
Cached Biology Technology:Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3
(Date:7/29/2014)... fascinating journey to the edge of science, Clment Vidal ... The Beginning and the End: Does our universe have ... Are we alone in the universe? What is the ... Grounded in science and committed to philosophical rigor, the ... intelligent life is not an accident, but may well ...
(Date:7/29/2014)... comes to technology, healthcare is usually one of the last industries ... comes to wearables, healthcare is trying to move ahead of the ... and its wearable cousins is less than mature, these devices are ... in the hospital for a major procedure or for personal use ... mind, InformationWeek editor Rodney Brown set out to ...
(Date:7/29/2014)... personal genetics company, has received from the National ... for a two-year project to support the further ... for genetic discovery. , Specifically, the grant ... of web-based surveys to improve the company,s ability ... of survey tools to support the collection of ...
Breaking Biology News(10 mins):Book: 'The Beginning and the End' 223andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 223andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 3
... found that the number of pests and disease outbreaks in ... The review "The consequences of Tree Pests and ... Southampton, Cambridge, Oxford and St Andrews is published today (15 ... shows that the experience of widespread death of trees, similar ...
... Clinic Lerner Research Institute have discovered recent genetic mutations ... of malaria annuallychanges that may render tens of millions ... infection. Peter A. Zimmerman, professor of international health, ... of Medicine, and David Serre, a scientific staff member ...
... , Nov. 14, 2013 Wake Forest Baptist Medical ... first-of-its-kind strategic affiliation agreement in the Triad with Cornerstone ... Cornerstone Health Enablement Strategic Solutions, LLC (CHESS). ... both partners for new models of health care delivery ...
Cached Biology News:Rising concerns over tree pests and diseases 2Vivax malaria may be evolving around natural defense 2Vivax malaria may be evolving around natural defense 3Wake Forest Baptist Medical Center and Cornerstone Health Care Join in Unique Affiliation 2Wake Forest Baptist Medical Center and Cornerstone Health Care Join in Unique Affiliation 3
... The Bio-Plex suspension array system, 100-240 V, ... for simultaneous quantitative analysis of up to ... microplate well. The suspension array is composed ... each of which may be conjugated with ...
...
... Disposable. Virgin, optically clear polystyrene with ... alphanumeric coordinates for cell counting. 100% ... is a new product number, created ... If showing no availability yet, please ...
... 100 IS System is a compact analysis system ... lasers, optics, fluidics, a controller, advanced digital signal ... compact lab analysis system includes the Luminex 100, ... has a DMF file at the FDA, and ...
Biology Products: